ANVISA registration 10071770948Valid until Jul 27, 2036

STAPHYLOCOCCUS SP

Name: STAPHYLOCOCCUS SP — ANVISA registration 10071770948
Creator: ABBOTT DIAGNOSTICS SCARBOROUGH, INC
Keywords: STAPHYLOCOCCUS SP, STAPHYLOCOCCUS SP, Clearview PBP2a SA, 10071770948, Risk Class III, ANVISA registration

ANVISA Registration Number: 10071770948ABBOTT DIAGNOSTICOS RAPIDOS S.A.ABBOTT DIAGNOSTICS SCARBOROUGH, INCRisk Class III

Verified

Device names

Technical name: STAPHYLOCOCCUS SP
Commercial name: Clearview PBP2a SA
Risk class: Class III

Registration details

Registration Number: 10071770948
Process Number: 25351052702202667
CNPJ: 50248780000161

Company information

Registration Holder: ABBOTT DIAGNOSTICOS RAPIDOS S.A.
Manufacturer: ABBOTT DIAGNOSTICS SCARBOROUGH, INC
Manufacturing Country: United States

Dates and status

Publication Date: Jul 27, 2026
Validity: 27/07/2036
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for STAPHYLOCOCCUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10071770948 and manufactured by ABBOTT DIAGNOSTICS SCARBOROUGH, INC. The registration is held by ABBOTT DIAGNOSTICOS RAPIDOS S.A. with validity until Jul 27, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.